Effects of Saiboku-to on the survival of human eosinophils

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 21, Issue 5, 1999, Pages 327-330

  Tohda, Yuji ^a,c   Haraguchi, R ^a   Kubo, H ^a   Muraki, M ^a   Fukuoka, M ^a   Nakajima, S ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Allergy; Asthma; Cytokines; Eosinophil; Kampo; Saiboku to

Indexed keywords

CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; LEUKOTRIENE C4; MAJOR BASIC PROTEIN; NEUROTOXIN; PEROXIDASE; SAIBOKU TO; THROMBOCYTE ACTIVATING FACTOR;

ALLERGY; ARTICLE; ASTHMA; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; EFFECTOR CELL; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATION; NORMAL HUMAN;

CELL SURVIVAL; CYTOKINES; DRUGS, CHINESE HERBAL; EOSINOPHILS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-3; INTERLEUKIN-5; MEDICINE, KAMPO; TIME FACTORS;

EID: 0032966842     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1999.21.5.541909     Document Type: Article

References (14)

1. Frigas, E., Gleich, G. J. The eosinophil and the pathology of asthma. J Allergy Clin Immunol 1986, 77: 527-37.
2. Kay, A.B., Ying, S., Varney, V. et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony stimulating factor, in allergen induced late phase cutaneous reaction atopic subject. J Exp Med 1991, 173: 775.
3. Kita, H., Ohnishi, T., Okubo, Y., Weiler, D., Abrams, J.S., Gleich, G. J. Granulocyte/macrophage colony stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991, 174: 745.
4. Eda, R., Takahashi, K., Tada, S. et al. Effects of "TSUMURA Saiboku-to" (TJ-96) on lymphokine production in patients with intractable asthma. Kampo Immuno-allergy 1990, 4: 104-14.
5. Tohda, Y., Haraguchi, R., Nagasaka, Y., Nakajima, S. Effect of Saiboku-to on lymphocytes. Kampo Immuno-allergy 1994, 8: 10-5.
6. Tei, M. Saiboku-to (1)-Kampo Igaku (Kampo Medicine) 1995, 19: 363-7.
7. Kobayashi, S., Fueki, R., Noguchi, H. Studies on long term administration of Saiboku-to extract preparation in bronchial asthma. Walcan Iyaku Kaishi (J Kampo Med Soc) 1995, 2: 598-9.
8. Nagano, H., Kobayashi, S., Nakajima, S. et al. Studies on long-term administration of Saiboku-to in bronchial asthma. Kokyuu (Resp Res) 1988, 7: 76-87.
9. Okudaira, H., Miyamoto, A. Efficacy of Saiboku-to in steroid-dependent asthma. Kampo Immuno-allergy 1989, 3: 175-81.
10. Nakajima, S., Doi, Y., Ohkawa, K. Efficacy in steroid-dependent asthma and effect of glucocorticoid receptor of Saiboku-to. Kampo Igaku (Kampo Medicine) 1987, 11(2): 28-34.
11. Arimura, H., Enohara, H., Koike, T., Furusawa, S., Sisido, H. Effect of interferon-α and interferon-gamma on eosinophil production by interleukin 5 and granulocyte macrophage colony stimulating factor. Journal Dokkyo Univ Sch Med 1994, 225: 234.
12. Terashi, Y., Yukawa, T., Terashi, K., Toda, M., Makino, S. Studies on the effect of Saiboku-to administration on lymphocyte subsets. Kampo Immuno-allergy 1994, 8: 132-41.
13. Tohda, Y., Haraguchi, R., Nakahara, H., Iwanaga, K., Nakajima, S. Effect of Saiboku-to on the cylokine production by peripheral blood mononuclear cells of patients with bronchial asthma. Kampo Immuno-allergy 1995, 9: 38-45.
14. Pene, J., Rousset, F., Chretien, I., Wideman, J., Bonnetoy, J.Y., Derries, J.E. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cell. The role of soluble CD23 antigen. Eur J Immunol 1988, 18: 928-35.